Sientra Inc. (SIEN) Sees Large Volume Increase
Sientra Inc. (NASDAQ:SIEN) shares saw unusually-strong trading volume on Monday . Approximately 146,019 shares traded hands during mid-day trading, an increase of 18% from the previous session’s volume of 124,113 shares.The stock last traded at $7.27 and had previously closed at $7.02.
Separately, Zacks Investment Research downgraded Sientra from a “hold” rating to a “sell” rating in a research report on Wednesday, April 13th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Sientra currently has a consensus rating of “Buy” and a consensus target price of $28.50.
The company’s 50-day moving average is $6.96 and its 200-day moving average is $7.19. The stock’s market cap is $128.49 million.
Sientra (NASDAQ:SIEN) last released its quarterly earnings results on Thursday, May 5th. The company reported ($0.66) EPS for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.08. On average, analysts expect that Sientra Inc. will post ($2.03) EPS for the current fiscal year.
A hedge fund recently bought a new stake in Sientra stock. Globeflex Capital L P purchased a new position in shares of Sientra Inc. (NASDAQ:SIEN) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 181,200 shares of the company’s stock, valued at approximately $1,073,000. Globeflex Capital L P owned approximately 1.01% of Sientra as of its most recent filing with the SEC.
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.